MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$3,006K
Prepaid expenses and
other current assets
$392K
Total current assets
$3,398K
Operating lease
right-of-use asset
$1,052K
Other assets
$948K
Property and equipment,
net
$162K
Total assets
$5,560K
Accumulated deficit
-$470,819K
Total liabilities and
stockholders' deficit
$5,560K
Total stockholders'
deficit
-$55,027K
Additional paid-in capital
$415,783K
Class a common stock,
0.0001 par value...
$9K
Total liabilities
$60,587K
Convertible notes at fair
value, including...
$34,600K
Derivative liability
$14,879K
Total current
liabilities
$6,897K
Warrant liabilities
$3,276K
Operating lease liability
$893K
Contingent consideration
liability
$42K
Accrued compensation
$2,872K
Other accrued
expenses
$1,657K
Accrued clinical trials
expenses
$1,426K
Accounts payable
$942K
Back
Back
Balance Sheet
source: myfinsight.com
AEON Biopharma, Inc. (AEON)
AEON Biopharma, Inc. (AEON)